Search

Rashida A Karmali

from Brooklyn, NY
Age ~76
Get Report
Also known as:
Rashida R Karmali, Ra Karmali, Rashide A Karmali, Rashida R
Phone and address:
110 Livingston St, Brooklyn, NY 11201
(718) 797-4095
Connected to:
Audhut D Karmali, 51Muneera Karmali, 60Azeem A Karmally, 45Raehanna Karmally, 37Marina Karmalsky, 81Dariusz T Karman, 63Kristine S Karman, 46Mark C Karman, 36Timothy A Karman, 59Brian S Karmann, 46

Rashida Karmali Phones & Addresses

  • 110 Livingston St, Brooklyn, NY 11201 (718) 797-4095
  • 110 Livingston St APT 10B, Brooklyn, NY 11201 (718) 797-4095
  • 180 Montague St, Brooklyn, NY 11201 (718) 797-4095
  • 13 13Th St, New York, NY 10011 (212) 989-8141
  • 99 Wall St, New York, NY 10005 (212) 651-9653
  • Hackensack, NJ
  • 13 W 13Th St APT 3AN, New York, NY 10011 (212) 989-8141

Work

Company: Savvipharm Position: Chief technology officer

Education

Degree: JD - Juris Doctor School / High School: Rutgers University School of Law

Skills

Intellectual Property • Trademarks • Licensing • Copyright Law • Technology Transfer • Trade Secrets • Strategy • Commercialization • Start Ups • Pharmaceutical Industry • Patents • Venture Capital • Due Diligence • Patent Litigation • Mergers and Acquisitions • Clinical Development • Clinical Trials • Joint Ventures • Lifesciences • Biotechnology • Pharmaceutics • Corporate Governance • Patent Prosecution • Private Equity • Competitive Intelligence • Life Sciences

Languages

English • French

Ranks

Licence: New York - Currently registered Date: 1994

Industries

Legal Services

Specialities

Technology Law • Technology Business Startups • Technology Finance • Technology Protection • Intellectual Property Valuation • Intellectual Property Portfolio Management • Intellectual Property Licensing • Intellectual Property Rights

Professional Records

Lawyers & Attorneys

Rashida Karmali Photo 1

Rashida A. Karmali, New York NY - Lawyer

View page
Address:
Rashida A. Karmali
99 Wall Street 13Th Floor, New York, NY 10005
Licenses:
New York - Currently registered 1994
Education:
Rutgers University School of Law
Degree - JD - Juris Doctor - Law
Graduated - 1993
University of New Castle
Degree - PhD - Doctorate - Biochemistry
Graduated - 1976
Makerere University
Degree - B.Sc
Graduated - 1971
Specialties:
Intellectual Property - 40%
Business - 40%
Venture Capital - 20%
Associations:
Association of the Bar of New York City - Patents Committee, 1996-2000
Association of the Bar of New York City - Patents Committee, 1992-1993
American Intellectual Property Law Association
Association of the Bar of New York City - Member
Rashida Karmali Photo 2

Rashida Karmali, New York NY - Lawyer

View page
Office:
Rashida A. Karmali
99 Wall Street, 23Rd Floor, New York, NY 10005
Phone:
(212) 651-9653 (Phone)
Specialties:
Technology Law
Technology Business Startups
Technology Finance
Technology Protection
Intellectual Property Valuation
Intellectual Property Portfolio Management
Intellectual Property Licensing
Intellectual Property Rights
Memberships:
The Association of the Bar of the City of New York
American Bar Association (Member: Patents Committee, 1992-1993
1996-2000)
American Intellectual Property Law Association
Licensing Executives Society
Certified Licensing Professional
American Society Clinical Oncology.
ISLN:
900422919
Admitted:
1994, New York
registered to practice before U.S. Patent and Trademark Office
University:
Makerere University, B.Sc., 1971
Aberdeen University, M.Sc., 1973
University of New Castle on Tyne, England, Ph.D., Biochemistry, 1976
Rutgers Business School, Newark, M.B.A., 2007
Law School:
Rutgers University School of Law, Newark, J.D., 1993
Languages:
French
Biography:
Author: "Bridging the Gap Between Expectations and Realty in Licensing Technology," The Licensing J 18:5 (1998); "Dietary Fatty Acids, COX-2 Blockade and Carcinogenesis," COX-2 Blockade in Cancer Prev...
Rashida Karmali Photo 3

Rashida A Karmali

Resumes

Resumes

Rashida Karmali Photo 4

Rashida Karmali

View page
Location:
99 Wall Street Ct, New York, NY 10005
Industry:
Legal Services
Work:
Savvipharm
Chief Technology Officer
Tactical Therapeutics
Chief Executive Officer
Tactical Therapeutics
Chief Executive Offi
Skills:
Intellectual Property
Trademarks
Licensing
Copyright Law
Technology Transfer
Trade Secrets
Strategy
Commercialization
Start Ups
Pharmaceutical Industry
Patents
Venture Capital
Due Diligence
Patent Litigation
Mergers and Acquisitions
Clinical Development
Clinical Trials
Joint Ventures
Lifesciences
Biotechnology
Pharmaceutics
Corporate Governance
Patent Prosecution
Private Equity
Competitive Intelligence
Life Sciences
Languages:
English
French

Business Records

Name / Title
Company / Classification
Phones & Addresses
Rashida Karmali
COO, executive officer
Karmali, Rashida A
Offices of Lawyers
99 Wall St #13, New York, NY 10005
(212) 651-9653
Rashida Karmali
Attorney Us
TACTICAL THERAPEUTICS, INC
Development of Safe Pharmaceutics for Cancer Therapeutics · Mfg Pharmaceutical Preparations
99 Wall St 23, New York, NY 10005
44 Wall St, New York, NY 10005
99 Wall St, New York, NY 10005
(212) 651-9653
Rashida Karmali
Chief Executive Officer
SAVVIPHARM, INC
Mfg Pharmaceutical Preparations
44 Wall St STE 2003, New York, NY 10005
99 Wall St, New York, NY 10005
(212) 651-9653
Rashida A. Karmali
KOOL CAP INC
Attn: Rashida A Karmali 99 Wall St, New York, NY 10005
99 Wall St 10, New York, NY 10005

Publications

Us Patents

Cool Cap

View page
US Patent:
D465641, Nov 19, 2002
Filed:
Aug 29, 2000
Appl. No.:
29/128641
Inventors:
Lloyd Provenzano - Naples FL, 34108
Rashida Karmali - New York NY, 10011
International Classification:
0203
US Classification:
D 2882

Specimen Collecting, Processing And Analytical Assembly

View page
US Patent:
7378054, May 27, 2008
Filed:
Apr 16, 2004
Appl. No.:
10/826083
Inventors:
Rashida A. Karmali - New York NY, US
Assignee:
Savvipharm Inc - New York NY
International Classification:
B01L 3/00
US Classification:
422 57, 422 58, 422 61, 422 99, 422102
Abstract:
A specimen collecting, processing and analytical assembly, designed for testing small volumes of body fluids, substances and secretions, said assembly comprising a one piece barrel assembly with a volumetrically graduated capillary tube having an open end, and optionally coated internally with an anticoagulant, a stabilizer or a preservative. The barrel assembly includes a filter membrane fitted above the capillary end at the junction of the barrel assembly and the capillary tube, a support means at the barrel's second open end, and an analytical testing means disposed there between. The invention also provides a sealed vial containing an analytical testing reagent, the vial being substantially airtight and sealed with a pierceable material, a first tip cap for closing the open end of the capillary tube, a second cap to close sealably the second open end of the barrel container and a lancet to induce capillary skin punctures.

Compositions And Methods Of Reducing Tissue Levels Of Drugs When Given As Orotate Derivatives

View page
US Patent:
7470672, Dec 30, 2008
Filed:
Jul 31, 2006
Appl. No.:
11/496255
Inventors:
Rashida A. Karmali - Brooklyn NY, US
Assignee:
Savvipharm Inc. - New York NY
International Classification:
A61K 31/704
A61K 31/506
US Classification:
514 34, 514274, 514459, 514721
Abstract:
This invention is in the field of chemical restructuring of pharmaceutical agents known to cause tissue toxicity as a side effect, by producing their orotate derivatives. More particularly, it concerns orotate derivatives of the anthracyclines, doxorubicin and daunorubicin, that are found to reduce levels of the pharmaceutical agent in noncancerous tissues. There orotate derivatives are equally efficacious in inhibiting the SCCAKI-1 kidney tumor in animals and the reduction in the heart tissue of doxorubicin compared with doxorubicin HCl suggests a reduction in toxicity induced by free radical generation by the anthrracyclines.

Compositions And Methods Of Reducing Side Effects And Toxicity Of Methotrexate When Given As Orotate Derivatives

View page
US Patent:
7601834, Oct 13, 2009
Filed:
Jan 18, 2007
Appl. No.:
11/655801
Inventors:
Rashida A. Karmali - Brooklyn NY, US
Assignee:
SavviPharm Inc - New York NY
International Classification:
C07D 475/08
A61K 31/519
US Classification:
544260, 5142621
Abstract:
This invention is in the field of chemical restructuring of antimetabolite agents known to have poor oral bioavailability and to cause tissue toxicity as a side effect, by producing their orotate derivatives. More particularly, it concerns orotate derivatives of the methotrexate and trimetrexate, that are found to improve the oral bioavailability and clearance compared with their respective forms—methotrexate and trimetrexate, currently in use. The present invention provides methotrexate orotate having the formula:.

Use Of Carboxiamidotriazole (Cai) Orotate In Macular Degeneration

View page
US Patent:
7750018, Jul 6, 2010
Filed:
Dec 6, 2006
Appl. No.:
11/634422
Inventors:
Rashida A. Karmali - Brooklyn NY, US
Assignee:
Tactical Therapeutics, Inc - New York NY
International Classification:
A61K 31/505
US Classification:
514274, 51421002, 514532, 514 54
Abstract:
Method and composition of Carboxyamidotriazole orotate for treating age-related macular degeneration and other angiogenesis-dependent diseases.

Method Of Reducing Cardiac Levels Of Doxorubicin When Given As Orotate Salt

View page
US Patent:
8148339, Apr 3, 2012
Filed:
Dec 12, 2008
Appl. No.:
12/316548
Inventors:
Rashida A. Karmali - Brooklyn NY, US
Assignee:
Savvipharm Inc - New York NY
International Classification:
A61K 31/704
US Classification:
514 34
Abstract:
This invention is in the field of chemical restructuring of pharmaceutical agents known to cause tissue toxicity as a side effect, by producing their orotate salts. More particularly, it concerns orotate salts of the anthracyclines, doxorubicin and daunorubicin, that are found to reduce levels of the pharmaceutical agent in noncancerous tissues. The orotate salts are equally efficacious in inhibiting the SCCAKI-1 kidney tumor in animals and the reduction in the heart tissue of doxorubicin compared with doxorubicin HCl suggests a reduction in toxicity induced by free radical generation by the anthracyclines.

Compositions And Processes For Preparing 5-Amino Or Substituted Amino 1,2,3-Triazoles And Triazole Orotate Formulations

View page
US Patent:
8377973, Feb 19, 2013
Filed:
Sep 3, 2010
Appl. No.:
12/807415
Inventors:
Rashida A. Karmali - Brooklyn NY, US
Assignee:
Tactical Therapeutics Inc - New York NY
International Classification:
A01N 43/64
A61K 31/41
US Classification:
514359, 548255
Abstract:
New polymorphs of 5-amino or substituted amino 1,2,3-triazole and substituted derivatives thereof, of orotates of the carboxyamidotriazoles, of formulations of the triazoles and orotic acid in the ratio of 1:1 to 1:4 (base:acid) and of safer processes of the preparation of the same are disclosed. The compounds are useful in the control and treatment of diseases including, but not limited to solid cancers, macular degeneration, retinopathy, chronic myeloid leukemia, AIDS and diseases which rely on aberrant signal transduction. The improved processes to prepare the orotate formulations use stable, efficient and safer starting azide intermediate materials in the synthesis of new polymorphs of carboxyamidotriazole.

Pharmaceutical Compositions Containing Paclitaxel Orotate

View page
US Patent:
8415388, Apr 9, 2013
Filed:
Apr 25, 2011
Appl. No.:
13/066793
Inventors:
Rashida A. Karmali - Brooklyn NY, US
Assignee:
Savvipharm Inc. - New York NY
International Classification:
A61K 31/335
C07D 305/14
US Classification:
514449, 549510
Abstract:
This invention is related to orotic acid compounds of taxane cytotoxic agents and in particular to the conversion of the taxanes to their orotate esters. More particularly the pharmaceutical compositions of paclitaxel orotate and docetaxel orotate provide a strategy to minimize body weight loss during primary chemotherapy and improve patient outcomes and quality of life.
Control profile
Rashida A Karmali from Brooklyn, NY, age ~76 Get Report